AIMS/HYPOTHESIS: It is well established that acute pancreatitis often causes diabetes and that a high blood glucose level associated with pancreatitis is a marker of poor prognosis. The aim of this study was to evaluate if diabetes merely reflects the severity of pancreatitis or whether it can also aggravate the progression of this disease in a vicious circle. METHODS: Reversible acute oedematous pancreatitis was induced in untreated and streptozotocin-treated diabetic mice by injection of cerulein. Progression of pancreatitis was studied by immunohistochemistry, ELISA and various other enzyme assays. The production of regenerating islet-derived 3β (REG3β) was determined by western blot and immunohistochemistry. RESULTS: While cerulein treatment in non-diabetic mice resulted in acute pancreatitis followed by regeneration of the pancreas within 7 days, diabetes aggravated pancreatitis, inhibited the regeneration of the exocrine tissue and led to strong atrophy of the pancreas. The aggravation of pancreatitis by diabetes was characterised by decreased production of the anti-inflammatory protein REG3β, increased inflammation, augmented oedema formation and increased cell death during the acute phase of pancreatitis (p < 0.05). During the regenerative phase, diabetes augmented inflammation, increased cell death, reduced acinar cell expansion and increased the expansion of duct as well as interstitial cells, resulting in the formation of tubular complexes (p < 0.05). Administration of insulin reversed the observed phenotype in diabetic mice. CONCLUSIONS/ INTERPRETATION: Diabetes aggravates acute pancreatitis and suppresses regeneration of the exocrine tissue. Thus, diabetes is not just a concomitant phenomenon of pancreatitis, but can have a fundamental influence on the progression of acute pancreatitis.
AIMS/HYPOTHESIS: It is well established that acute pancreatitis often causes diabetes and that a high blood glucose level associated with pancreatitis is a marker of poor prognosis. The aim of this study was to evaluate if diabetes merely reflects the severity of pancreatitis or whether it can also aggravate the progression of this disease in a vicious circle. METHODS: Reversible acute oedematous pancreatitis was induced in untreated and streptozotocin-treated diabeticmice by injection of cerulein. Progression of pancreatitis was studied by immunohistochemistry, ELISA and various other enzyme assays. The production of regenerating islet-derived 3β (REG3β) was determined by western blot and immunohistochemistry. RESULTS: While cerulein treatment in non-diabeticmice resulted in acute pancreatitis followed by regeneration of the pancreas within 7 days, diabetes aggravated pancreatitis, inhibited the regeneration of the exocrine tissue and led to strong atrophy of the pancreas. The aggravation of pancreatitis by diabetes was characterised by decreased production of the anti-inflammatory protein REG3β, increased inflammation, augmented oedema formation and increased cell death during the acute phase of pancreatitis (p < 0.05). During the regenerative phase, diabetes augmented inflammation, increased cell death, reduced acinar cell expansion and increased the expansion of duct as well as interstitial cells, resulting in the formation of tubular complexes (p < 0.05). Administration of insulin reversed the observed phenotype in diabeticmice. CONCLUSIONS/ INTERPRETATION:Diabetes aggravates acute pancreatitis and suppresses regeneration of the exocrine tissue. Thus, diabetes is not just a concomitant phenomenon of pancreatitis, but can have a fundamental influence on the progression of acute pancreatitis.
Authors: Yarong Lu; André Ponton; Hiroshi Okamoto; Shin Takasawa; Pedro L Herrera; Jun-Li Liu Journal: Am J Physiol Endocrinol Metab Date: 2006-01-31 Impact factor: 4.310
Authors: Jens T Siveke; Clara Lubeseder-Martellato; Marcel Lee; Pawel K Mazur; Hassan Nakhai; Freddy Radtke; Roland M Schmid Journal: Gastroenterology Date: 2007-11-04 Impact factor: 22.682
Authors: Dale E Bockman; Junchao Guo; Peter Büchler; Michael W Müller; Frank Bergmann; Helmut Friess Journal: Lab Invest Date: 2003-06 Impact factor: 5.662
Authors: Aliye Uc; Dana K Andersen; Melena D Bellin; Jason I Bruce; Asbjørn M Drewes; John F Engelhardt; Christopher E Forsmark; Markus M Lerch; Mark E Lowe; Brent A Neuschwander-Tetri; Stephen J OʼKeefe; Tonya M Palermo; Pankaj Pasricha; Ashok K Saluja; Vikesh K Singh; Eva M Szigethy; David C Whitcomb; Dhiraj Yadav; Darwin L Conwell Journal: Pancreas Date: 2016-11 Impact factor: 3.327
Authors: Pedram Paragomi; Georgios I Papachristou; Kwonho Jeong; Alice Hinton; Ioannis Pothoulakis; Rupjyoti Talukdar; Rakesh Kochhar; Mahesh K Goenka; Aiste Gulla; Jose A Gonzalez; Vikesh K Singh; Miguel Ferreira Bogado; Tyler Stevens; Sorin T Barbu; Haq Nawaz; Silvia C Gutierrez; Narcis Zarnescu; Livia Archibugi; Jeffrey J Easler; Konstantinos Triantafyllou; Mario Peláez-Luna; Shyam Thakkar; Carlos Ocampo; Enrique de-Madaria; Gregory A Cote; Bechien U Wu; Peter J Lee; Phil A Hart; Darwin L Conwell; Frederico G S Toledo; Dhiraj Yadav Journal: Pancreatology Date: 2021-10-10 Impact factor: 3.996
Authors: Jason I E Bruce; Rosa Sánchez-Alvarez; Maria Dolors Sans; Sarah A Sugden; Nathan Qi; Andrew D James; John A Williams Journal: Nat Commun Date: 2021-07-19 Impact factor: 14.919
Authors: Aysha Samad; Andrew James; James Wong; Parini Mankad; John Whitehouse; Waseema Patel; Marta Alves-Simoes; Ajith K Siriwardena; Jason I E Bruce Journal: J Biol Chem Date: 2014-07-03 Impact factor: 5.157